Bora Pharmaceuticals Capacity Update April 2025: Fill/Finish

Bora Pharmaceuticals is a full-service global CDMO specializing in the development and manufacturing of complex oral solid, liquid, semi-solid, ophthalmic, biologics, and sterile injectable products for clinical and commercial supply. Our comprehensive solutions and expansive global network enable our clients to deliver much-needed therapies to patients worldwide.

In this presentation, Tara Lorenz, Sr. Director of Commercial Operations, will provide an update on Bora’s latest investments and expanded fill/finish capabilities and capacity for small molecules, biologics, and other sterile injectable products. The 87,000 sq.ft. cGMP facility located in Baltimore, Maryland, USA, boasts a state-of-the-art Groninger isolator filling line designed for flexible and scalable manufacturing of vials, syringes, and cartridges and offers inspection, labeling, and packaging solutions as well as comprehensive on-site analytical and testing services. In addition, Lorenz will share an overview of Bora’s innovative virtual reality training and development program, aimed at enhancing aseptic practices, increasing operational efficiency, and delivering exceptional quality and reliability at every step of the manufacturing process.

With extensive experience in tech transfer and scale up to commercialization, Bora is well equipped to support your unique cGMP program needs.